[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100382769":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":35,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":7,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":41,"conditions":48,"keywords":51,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Henan Cancer Hospital","OTHER_GOV",null,[9],{"name":10,"affiliation":5,"role":11},"Yanyan Liu, M.D. Ph.D","STUDY_DIRECTOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+8613818176375","yyliu@zzu.edu.cn",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":7,"country":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Henan Cancer Hospital\u002FThe affiliated Cancer Hospital of ZhengZhou university","RECRUITING","Zhengzhou","Henan","China",{"type":25,"coordinates":26},"Point",[27,28],113.64861,34.75778,{"lat":28,"lon":27},[31,33],{"name":10,"role":14,"phone":32,"phoneExt":7,"email":16},"+8613838176375",{"name":10,"role":34,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"type":34,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Yanyan Liu","Director","100382769",false,"NCT04263935","Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma","Inclusion Criteria:\n\n1. Diagnosed as lymphoma (according to WHO 2017 classification criteria)\n2. Life expectancy no less than 3 months\n3. Agreeing to sign the written informed consents\n\nExclusion Criteria:\n\n1. Other malignant tumor history or active malignant tumor need be treated\n2. Researchers determine unsuited to participate in this trial","ALL",{"count":45,"type":46},200,"ESTIMATED","OBSERVATIONAL",[49,50],"Lymphoma","Gene Abnormality",[49,52,53],"Driver Gene Abnormalities","Disease Prognosis","2025-04-18",{"date":56,"type":57},"2025-04-23","ACTUAL",{"date":59,"type":57},"2019-01-03",{"date":61,"type":46},"2025-12-31",{"name":5,"class":6},1]